NFKBIL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.928200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.133200E-01
Normal-vs-Stage2
2.882800E-01
Normal-vs-Stage3
5.959800E-01
Normal-vs-Stage4
3.495200E-01
Stage1-vs-Stage2
4.597600E-01
Stage1-vs-Stage3
9.906800E-01
Stage1-vs-Stage4
7.659200E-01
Stage2-vs-Stage3
5.543000E-01
Stage2-vs-Stage4
7.009200E-01
Stage3-vs-Stage4
8.489400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.000200E-01
Normal-vs-AfricanAmerican
5.770800E-01
Normal-vs-Asian
7.007900E-02
Caucasian-vs-AfricanAmerican
3.733600E-01
Caucasian-vs-Asian
7.065400E-01
AfricanAmerican-vs-Asian
1.266250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.518800E-01
Normal-vs-Female
3.408400E-01
Male-vs-Female
8.010600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.409200E-01
Normal-vs-Age(41-60Yrs)
3.613600E-01
Normal-vs-Age(61-80Yrs)
2.500400E-01
Normal-vs-Age(81-100Yrs)
2.053200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.899800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.739380E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.310280E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.560400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.250200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.024400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.265000E-01
Normal-vs-Daily Drinker
2.178400E-01
Normal-vs-Weekly Drinker
2.434400E-01
Normal-vs-Occasional Drinker
2.655000E-01
Normal-vs-Social Drinker
3.619000E-01
Non Drinker-vs-Daily Drinker
9.024000E-01
Non Drinker-vs-Weekly Drinker
7.858800E-01
Non Drinker-vs-Occasional Drinker
8.625000E-01
Non Drinker-vs-Social Drinker
2.726000E-01
Daily Drinker-vs-Weekly Drinker
6.743000E-01
Daily Drinker-vs-Occasional Drinker
7.574600E-01
Daily Drinker-vs-Social Drinker
3.122200E-01
Weekly Drinker-vs-Occasional Drinker
9.144400E-01
Weekly Drinker-vs-Social Drinker
2.273800E-01
Occasional Drinker-vs-Social Drinker
2.645800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.351600E-01
Normal-vs-Grade 2
7.662400E-01
Normal-vs-Grade 3
8.126600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.322050E-01
Grade 1-vs-Grade 3
3.039000E-03
Grade 1-vs-Grade 4
4.351600E-01
Grade 2-vs-Grade 3
4.366200E-02
Grade 2-vs-Grade 4
7.662400E-01
Grade 3-vs-Grade 4
8.126600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.936400E-01
Normal-vs-NonDiabetic
2.672400E-01
Diabetic-vs-NonDiabetic
3.919200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.534490E-02
Normal-vs-NoPancreatitis
3.082000E-01
Pancreatitis-vs-NoPancreatitis
7.444200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.601040E-01
Normal-vs-N1
3.305600E-01
N0-vs-N1
7.852000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.662400E-02
Normal-vs-TP53-NonMutant
4.237200E-01
TP53-Mutant-vs-TP53-NonMutant
2.20299999997842E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
